Health
AstraZeneca-Oxford manufacturing error clouds vaccine study results – Nikkei Asia
University says some vials in the trial didn’t have right concentration of vaccine
LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.
A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected.
In a surprise, the group of volunteers that got a lower dose seemed…
-
Business17 hours ago10 ASX shares to buy after the market selloff
-
General20 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business16 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General19 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening